The discovery of neuromedin U and its pivotal role in the central regulation of energy homeostasis;Odkrycie neuromedyny U i jej rola w centralnej regulacji homeostazy energetycznej

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 66, Issue , 2012, Pages 196-203

  Kirsz, Katarzyna ^a   Ziȩba, Dorota A ^a  

^a Pracownia Biotechnologii i Genomiki   (Poland)

Author keywords

Energy homeostasis; Food intake; G protein coupled receptors; Neuromedin U and S; Obesity; Signal transduction

Indexed keywords

EID: 84867944152     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: 10.5604/17322693.991448     Document Type: Review

References (49)

1. Austin C., Lo G., Nandha K. A., Meleagros L., Bloom S. R.: Cloning and characterization of the cDNA encoding the human neuromedin U (NmU) precursor: NmU expression in the human gastrointestinal tract. J. Mol. Endocrinol., 1995;14:157-169
2. Berthoud H. R.: Multiple neural systems controlling food intake and body weight. Neurosci. Biobehav. Rev., 2002;26:393-428
3. Branca F., Nikogosian H., Lobstein T.: The challenge of obesity in the WHO European Region and the strategies for response. WHO Regional Office for Europe. Copenhagen 2007
4. Brighton P. J., Szekeres P. G., Aiyar N., Willars G. B.: Characterisation of signalling by recombinant human neuromedin-U receptors. Br. J. Pharmacol., 2003;140:75
5. Brighton P. J., Szekeres P. G., Willars G. B.: Neuromedin U and its receptors: structure, function, and physiological roles. Pharmacol. Rev., 2004;56:231-248
6. Brighton P. J., Szekeres P. G., Wise A., Willars G. B.: Signaling and ligand binding by recombinant neuromedin U receptors: evidence for dual coupling to Galphaq/11 and Galphai and an irreversible ligand-receptor interaction. Mol. Pharmacol., 2004;66:1544-1556
7. Brighton P. J., Wise A., Dass N. B., Willars G. B.: Paradoxical behavior of neuromedin U in isolated smooth muscle cells and intact tissue. J. Pharmacol. Exp. Ther., 2008;325:154-164
8. Davare M. A., Hell J. W.: Increased phosphorylation of the neuronal L-type Ca2+ channel Ca (v) 1.2 during aging. Proc. Natl. Acad. Sci. USA, 2003;100:16018-16023
9. Deng H. W., Deng H., Liu Y. J., Liu Y. Z., Xu F. H., Shen H., Conway T., Li J. L., Huang Q. Y., Davies K. M., Recker R. R.: A genome wide linkage scan for quantitative-trait loci for obesity phenotypes. Am. J. Hum. Genet., 2002;70:1138-1151
10. Funes S., Hedrick J. A., Yang S., Shan L., Bayne M., Monsma F. J. Jr, Gustafson E. L.: Cloning and characterization of murine neuromedin U receptors. Peptides, 2002;23:1607-1615
11. Graham E. S., Turnbull Y., Fotheringham P., Nilaweera K., Mercer J. G., Morgan P. J., Barrett P.: Neuromedin U and neuromedin U receptor-2 expression in the mouse and rat hypothalamus: effects of nutritional status. J. Neurochem., 2003;87:1165-1173
12. Hainerová I., Torekov S. S., Ek J., Finková M., Borch-Johnsen K., Jørgensen T., Madsen O. D., Lebl J., Hansen T., Pedersen O.: Association between neuromedin U gene variants and overweight and obesity. J. Clin. Endocrinol. Metab., 2006;91:5057-5063
13. Hanada T., Date Y., Shimbara T., Sakihara S., Murakami N., Hayashi Y., Kanai Y., Suda T., Kangawa K., Nakazato M.: Central actions of neuromedin U via corticotropin-releasing hormone. Biochem. Biophys. Res. Commun., 2003;311:954-958
14. Hanada R., Teranishi H., Pearson J. T., Kurokawa M., Hosoda H., Fukushima N., Fukue Y., Serino R., Fujihara H., Ueta Y., Ikawa M., Okabe M., Murakami N., Shirai M., Yoshimatsu H., Kangawa K., Kojima M.: Neuromedin U has a novel anorexigenic effect independent of the leptin signaling pathway. Nat. Med., 2004;10:1067-1073
15. Hashimoto T., Masui H., Uchida Y., Sakura N., Okimura K.: Agonistic and antagonistic activities of neuromedin U-8 analogs substituted with glycine or D-amino acid on contractile activity of chicken crop smooth muscle preparations. Chem. Pharm. Bull., 1991;39:2319-2322
16. Hosoya M., Moriya T., Kawamata Y., Ohkubo S., Fujii R., Matsui H., Shintani Y., Fukusumi S., Habata Y., Hinuma S., Onda H., Nishimura O., Fujino M.: Identification and functional characterization of a novel subtype of neuromedin U receptor. J. Biol. Chem., 2000;275:29528-29532
17. Howard A. D., Wang R., Pong S. S., Mellin T. N., Strack A., Guan X. M., Zeng Z., Williams D. L. Jr, Feighner S. D., Nunes C. N., Murphy B., Stair J. N., Yu H., Jiang Q., Clements M. K., Tan C. P., McKee K. K., Hreniuk D. L., McDonald T. P., Lynch K. R., Evans J. F., Austin C. P., Caskey C. T., Van der Ploeg L. H., Liu Q.: Identification of reeptors for neuromedin U and its role in feeding. Nature, 2000;406:70-74
18. Hsu S. H., Luo C. W.: Molecular dissection of G protein preference using Gsa chimeras reveals novel ligand signaling of GPCRs. Am. J. Physiol. Endocrinol. Metab., 2007;293:E1021-E1029
19. Ida T., Mori K., Miyazato M., Egi Y., Abe S., Nakahara K., Nishihara M., Kangawa K., Murakami N.: Neuromedin S is a novel anorexigenic hormone. Endocrinology, 2005;146 4217-4223
20. Ivanov T. R., Lawrence C. B., Stanley P. J., Luckman S. M.: Evaluation of neuromedin U actions in energy homeostasis and pituitary function. Endocrinology, 2002;143:3813-3821
21. Jethwa P. H., Small C. J., Smith K. L., Seth A., Darch S. J., Abbott C. R., Murphy K. G., Todd J. F., Ghatei M. A., Bloom S. R.: Neuromedin U has a physiological role in the regulation of food intake and partially mediates the effects of leptin. Am. J. Physiol. Endocrinol. Metab., 2005;289:E301-E305
22. Kowalski T. J., Spar B. D., Markowitz L., Maguire M., Golovko A., Yang S., Farley C., Cook J. A., Tetzloff G., Hoos L., Del Vecchio R. A., Kazdoba T. M., McCool M. F., Hwa J. J., Hyde L. A., Davis H., Vassileva G., Hedrick J. A., Gustafson E. L.: Transgenic overexpression of neuromedin U promotes leanness and hypophagia in mice. J. Endocrinol., 2005;185:151-164
23. Lee W. H., Liu S. B., Shen J. H., Jin Y., Lai R., Zhang Y.: Identification and molecular cloning of a novel neuromedin U analog from the skin secretions of toad Bombina maxima. Regul. Pept., 2005;129:43-47
24. Maruyama K., Konno N., Ishiguro K., Wakasugi T., Uchiyama M., Shioda S., Matsuda K.: Isolation and characterisation of four cDNAs encoding neuromedin U (NMU) from the brain and gut of goldfish, and the inhibitory effect of a deduced NMU on food intake and locomotor activity. J. Neuroendocrinol., 2008;20:71-78
25. Minamino N., Kangawa K., Honzawa M., Matsuo H.: Isolation and structural determination of rat neuromedin U. Biochem. Biophys. Res. Commun., 1988;156:355-360
26. Minamino N., Kangawa K., Matsuo H.: Neuromedin U-8 and U-25: novel uterus stimulating and hypertensive peptides identified in porcine spinal cord. Biochem. Biophys. Res. Commun., 1985;130:1078-1085
27. Mitchell J. D., Maguire J. J., Kuc R. E., Davenport A. P.: Expression and vasoconstrictor function of anorexigenic peptides neuromedin U-25 and S in the human cardiovascular system. Cardiovasc. Res., 2009;81:353-361
28. Mori K., Miyazato M., Ida T., Murakami N., Serino R., Ueta Y., Kojima M., Kangawa K.: Identification of neuromedin S and its possible role in the mammalian circadian oscillator system. EMBO J., 2005;24:325-335
29. Mori K., Miyazato M., Kangawa K.: Neuromedin S: discovery and functions. Results Probl. Cell Differ., 2008;46:201-212
30. Nakahara K., Hanada R., Murakami N., Teranishi H., Ohgusu H., Fukushima N., Moriyama M., Ida T., Kangawa K., Kojima M.: The gut-brain peptide neuromedin U is involved in the mammalian circadian oscillator system. Biochem. Biophys. Res. Commun., 2004;318:156-161
31. Nakahara K., Katayama T., Maruyama K., Ida T., Mori K., Miyazato M., Kangawa K., Murakami N.: Comparison of feeding suppression by the anorexigenic hormones neuromedin U and neuromedin S in rats. J. Endocrinol., 2010;207:185-193
32. Niimi M., Murao K., Taminato T.: Central administration of neuromedin U activates neurons in ventrobasal hypothalamus and brainstem. Endocrine, 2001;16:201-206
33. Nogueiras R., Tovar S., Mitchell S. E., Barrett P., Rayner D. V., Dieguez C., Williams L. M.: Negative energy balance and leptin regulate neuromedin-U expression in the rat pars tuberalis. J. Endocrinol., 2006;190:545-553
34. Novak C. M., Zhang M., Levine J. A.: Sensitivity of the hypothalamic paraventricular nucleus to the locomotor-activating effects of neuromedin U in obesity. Brain Res., 2007;1169:57-68
35. Ogden C. L., Carroll M. D., Curtin L. R., McDowell M. A., Tabak C. J., Flegal K. M.: Prevalence of overweight and obesity in the United States, 1999-2004. JAMA, 2006;295:1549-1555
36. Ozaki Y., Onaka T., Nakazato M., Saito J., Kanemoto K., Matsumoto T., Ueta Y.: Centrally administered neuromedin U activates neurosecretion and induction of c-fos messenger ribonucleic acid in the paraventricular and supraoptic nuclei of rat. Endocrinology, 2002;143:4320-4329
37. Peier A. M., Desai K., Hubert J., Du X., Yang L., Qian Y., Kosinski J. R., Metzger J. M., Pocai A., Nawrocki A. R., Langdon R. B., Marsh D. J.: Effects of peripherally administered neuromedin U on energy and glucose homeostasis. Endocrinology, 2011;152:2644-2654
38. Peier A., Kosinski J., Cox-York K., Qian Y., Desai K., Feng Y., Trivedi P., Hastings N., Marsh D. J.: The antiobesity effects of centrally administered neuromedin U and neuromedin S are mediated predominantly by the neuromedin U receptor 2 (NMUR2). Endocrinology, 2009;150:3101-3109
39. Raddatz R., Wilson A. E., Artymyshyn R., Bonini J. A., Borowsky B., Boteju L. W., Zhou S., Kouranova E. V., Nagorny R., Guevarra M. S., Dai M., Lerman G. S., Vaysse P. J., Branchek T. A., Gerald C., Forray C., Adham N.: Identification and characterization of two neuromedin U receptors differentially expressed in peripheral tissues and the central nervous system. J. Biol. Chem., 2000;275:32452-32459
40. Sato S., Hanada R., Kimura A., Abe T., Matsumoto T., Iwasaki M., Inose H., Ida T., Mieda M., Takeuchi Y., Fukumoto S., Fujita T., Kato S., Kangawa K., Kojima M., Shinomiya K., Takeda S.: Central control of bone remodeling by neuromedin U. Nat. Med., 2007;13:1234-1240
41. Szekeres P. G., Muir A. I., Spinage L. D., Miller J. E., Butler S. I., Smith A., Rennie G. I., Murdock P. R., Fitzgerald L. R., Wu H., McMillan L. J., Guerrera S., Vawter L., Elshourbagy N. A., Mooney J. L., Bergsma D. J., Wilson S., Chambers J. K.: Neuromedin U is a potent agonist at the orphan G-protein-coupled receptor FM3. J. Biol. Chem., 2000;275:20247-20250
42. Takahashi K., Furukawa C., Takano A., Ishikawa N., Kato T., Hayama S., Suzuki C., Yasui W., Inai K., Sone S., Ito T., Nishimura H., Tsuchiya E., Nakamura Y., Daigo Y.: The neuromedin U-growth hormone secretagogue receptor 1b/neurotensin receptor 1 oncogenic signaling pathway as a therapeutic target for lung cancer. Cancer Res., 2006;66:9408-9419
43. Thompson E. L., Murphy K. G., Todd J. F., Martin N. M., Small C. J., Ghatei M. A., Bloom S. R.: Chronic administration of NMU into the paraventricular nucleus stimulates the HPA axis but does not influence food intake or body weight. Biochem. Biophys. Res. Commun., 2004;323:65-71
44. Vassilatis D. K., Hohmann J. G., Zeng H., Li F., Ranchalis J. E., Mortrud M. T., Brown A., Rodriguez S. S., Weller J. R., Wright A. C., Bergmann J. E., Gaitanaris G. A.: The G protein-coupled receptor repertoires of human and mouse. Proc. Natl. Acad. Sci. USA, 2003;100:4903-4908
45. Wang F., Zhang Y., Jiang X., Zhang Y., Zhang L., Gong S., Liu C., Zhou L., Tao J.: Neuromedin U inhibits T-type Ca2+ channel currents and decreases membrane excitability in small dorsal root ganglia neurons in mice. Cell Calcium, 2011;49:12-22
46. Wren A. M., Small C. J., Abbott C. R., Jethwa P. H., Kennedy A. R., Murphy K. G., Stanley S. A., Zollner A. N., Ghatei M. A., Bloom S. R.: Hypothalamic actions of neuromedin U. Endocrinology, 2002;143:4227-4234
47. Yamamoto I., Nakao N., Kaiya H., Miyazato M., Tsushima N., Arai T., Tanaka M.: Two chicken neuromedin U receptors: characterization of primary structure, biological activity and tissue distribution. Gen. Comp. Endocrinol., 2011;174:116-123
48. Zhang Y., Jiang D., Zhang J., Wang F., Jiang X., Tao J.: Activation of neuromedin U type 1 receptor inhibits L-type Ca2+ channel currents via phosphatidylinositol 3-kinase-dependent protein kinase C epsilon pathway in mouse hippocampal neurons. Cell. Signal., 2010;22:1660-1668
49. Zhao J., Bradfield J. P., Li M., Wang K., Zhang H., Kim C. E., Annaiah K., Glessner J. T., Thomas K., Garris M., Frackelton E. C., Otieno F. G., Shaner J. L., Smith R. M., Chiavacci R. M., Berkowitz R. I., Hakonarson H., Grant S. F.: The role of obesity-associated loci identified in genome-wide association studies in the determination of pediatric BMI. Obesity, 2009;17:2254-2257